[The pregnant woman infected with the human immunodeficiency virus: recommendations for her management].
Santana
J L
JL
Ramírez-Ronda
C H
CH
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000209:etiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy / Q000209:etiology; D014295:Trimethoprim / Q000627:therapeutic use
D014295:Trimethoprim; D013420:Sulfamethoxazole; D007654:Ketoconazole
La mujer embarazada infectada por el virus de inmunodeficiencia humana: recomendaciones para su manejo.